IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biomark Capital Management Co. LLC

Q3 2016 Holdings

Filed 2016-11-09 | 3 holdings | $10.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics, Inc.(ADMA)COM000899104$10.4M1,433,30499.4%
Juno Therapeutics, Inc.COM48205A109$65.1K2,168,6010.6%
Mabvax Therapeutics Holdings, Inc.COM NEW55414P504$11326,7080.0%